Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  The Lancet

• Publication date

  1994-11-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0140-6736(94)90287-9PMID 7526102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation.

  1994cited by this paper
• Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.

  1994cited by this paper
• Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial

  1993cited by this paper
• Therapeutic approaches to the control of fibrocellular intimal hyperplasia after angioplasty.

  1993cited by this paper
• Fixation with formaldehyde induces expression of activation dependent platelet membrane glycoproteins, P selectin (CD62) and GP53 (CD63)

  1993cited by this paper
• SIN‐1 Reduces Platelet Adhesion and Platelet Thrombus Formation in a Porcine Model of Balloon Angioplast

  1993cited by this paper
• Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial.

  1993cited by this paper
• Influence of platelet size before coronary angioplasty on subsequent restenosis

  1993cited by this paper
• Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide.

  1992cited by this paper
• S‐nitroso‐glutathione inhibits platelet activation in vitro and in vivo

  1992cited by this paper
• Migration of Smooth Muscle and Endothelial Cells: Critical Events in Restenosis

  1992cited by this paper
• Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection.

  1992cited by this paper
• Influence of platelet size on outcome after myocardial infarction.

  1991cited by this paper
• Acute Coronary Artery Occlusion During and After Percutaneous Transluminal Coronary Angioplasty: Frequency, Prediction, Clinical Course, Management, and Follow‐up

  1991cited by this paper
• Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF

  1991cited by this paper
• Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.

  1990cited by this paper
• An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

  1990cited by this paper
• Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery.

  1989cited by this paper
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

  1989cited by this paper
• Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug.

  1988cited by this paper
• Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

  1988cited by this paper
• Detection of activated platelets in whole blood using activation- dependent monoclonal antibodies and flow cytometry

  1987cited by this paper
• Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry.

  1987cited by this paper
• Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.

  1987cited by this paper
• Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience.

  1987cited by this paper
• Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.

  1987cited by this paper
• The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

  1987cited by this paper
• Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty.

  1985cited by this paper
• The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans.

  1984cited by this paper
• Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium.

  1978cited by this paper

• Nitric oxide and thiols: Chemical biology, signalling paradigms and vascular therapeutic potential

  2023cites this paper
• Photoactivation of tDodSNO induces localized vasodilation in rats: Metabolically stable S-nitrosothiols can act as targeted nitric oxide donors in vivo.

  2022cites this paper
• A Versatile Surface Bioengineering Strategy Based on Mussel-Inspired and Bioclickable Peptide Mimic

  2020cites this paper
• Effects of Nitrite and Far-red Light on Coagulation.

  2020cites this paper
• Investigation of S-Nitrosoglutathione in stroke: A systematic review and meta-analysis of literature in pre-clinical and clinical research.

  2020cites this paper
• Modulating the Bioactivity of Nitric Oxide as a Therapeutic Strategy in Cardiac Surgery.

  2020cites this paper
• Protective effect of S-nitrosoglutathione pretreatment on acute lung injury in septic rats

  2020cites this paper
• Comparação dos efeitos anti-hipertensivos da S-nitrosoglutationa livre e nanoencapsulada em modelo animal de hipertensão

  2020cites this paper
• Mechanisms of S-nitrosothiols intestinal permeability and NO store formation within vascular wall to improve NO oral delivery systems

  2019cites this paper
• The effect of inorganic nitrate and antiplatelet drugs on NO metabolites and platelet reactivity in patients with stable coronary artery disease

  2019cites this paper
• Investigating the role of nitrite in the cardiovascular system

  2019cites this paper
• Nitric oxide donor delivery

  2018cites this paper
• Integrated microfluidic device for the separation, decomposition and detection of low molecular weight S-nitrosothiols.

  2018cites this paper
• Electrochemical detection of nitric oxide and S-nitrosothiols in biological systems: Past, present & future

  2018cites this paper
• Pyrrole: An insight into recent pharmacological advances with structure activity relationship.

  2018cites this paper
• Oxidative stress enhances and modulates protein S-nitrosation in smooth muscle cells exposed to S-nitrosoglutathione.

  2017cites this paper
• Regulation of protein function by S-nitrosation and S-glutathionylation: processes and targets in cardiovascular pathophysiology

  2017cites this paper
• United States Patent ( 19 )

  2017cites this paper
• S-Nitrosothiols and Nitric Oxide Biology

  2017cites this paper
• Potential therapeutic action of nitrite in sickle cell disease

  2017cites this paper
• Polymer nanocomposites enhance S-nitrosoglutathione intestinal absorption and promote the formation of releasable nitric oxide stores in rat aorta.

  2016cites this paper
• Identifying and characterizing caveolin-1 derived peptides : a novel approach to promoting nitric oxide release from the endothelium

  2016cites this paper
• The effect of thienopyridines and non-thienopyridines on nitric oxide metabolism in patients with stable angina

  2016cites this paper
• Inflammation and oxidative stress in atherosclerosis : role of S-nitrosothiols in the vascular responses

  2016cites this paper
• Nitric oxide-releasing polyurethanes

  2016cites this paper
• Miniaturized devices for bioanalysis : case of nitric oxide stored as S-nitrosothiols in biological fluids

  2016cites this paper
• Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation.

  2015cites this paper
• Quantitation of Cu+‐catalyzed Decomposition of S‐Nitrosoglutathione Using Saville and Electrochemical Detection: a Pronounced Effect of Glutathione and Copper Concentrations

  2015cites this paper
• Recent Advances in Hemocompatible Polymers for Biomedical Applications

  2015cites this paper
• S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.

  2015cites this paper
• Vascular nitric oxide: Beyond eNOS.

  2015cites this paper
• The study of platelet indices in acute coronary syndromes

  2015cites this paper
• S-nitrosoglutathione efflux in the erythrocyte

  2015cites this paper
• The nitric oxide pathway and possible therapeutic options in pre‐eclampsia

  2014cites this paper
• S-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia.

  2014cites this paper
• Chapter 8 – Stable Ischemic Heart Disease/Chronic Stable Angina

  2013cites this paper
• Protective Role of S-Nitrosoglutathione (GSNO) Against Cognitive Impairment in Rat Model of Chronic Cerebral Hypoperfusion

  2013cites this paper
• Long-term nitric oxide release and elevated temperature stability with S-nitroso-N-acetylpenicillamine (SNAP)-doped Elast-eon E2As polymer.

  2013cites this paper
• Chapter 29 – Flow Cytometry

  2013cites this paper
• S-Nitrosoglutathione Acts as a Small Molecule Modulator of Human Fibrin Clot Architecture

  2012cites this paper
• Nitroglycerin and sodium nitroprusside: potential contributors to postoperative bleeding?

  2012cites this paper
• Erythrocyte as a biological sensor

  2012cites this paper
• S-nitrosation/denitrosation in cardiovascular pathologies: facts and concepts for the rational design of S-nitrosothiols.

  2012cites this paper
• Optimization of Cardiovascular Stent against Restenosis: Factorial Design-Based Statistical Analysis of Polymer Coating Conditions

  2012cites this paper
• The Molecular Design of S‐Nitrosothiols as Photodynamic Agents for Controlled Nitric Oxide Release

  2012cites this paper
• A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response.

  2012cites this paper
• Current developments in the therapeutic potential of S-nitrosoglutathione, an endogenous NO-donor molecule.

  2011cites this paper
• The effect of nitric oxide inhibitors and Snitroso-Nacetylpenicillamine on glucose concentration in an animal model

  2011cites this paper
• The Endothelium As Target for Interventions

  2011cites this paper
• Univerzita Palackého v Olomouci

  2011cites this paper
• Stöber Synthesis of Nitric Oxide-Releasing S-Nitrosothiol-Modified Silica Particles.

  2011cites this paper
• Estudo do papel do S-Nitrosoglutationa na doença periodontal experimental e na inflamação aguda

  2010cites this paper
• Endothelin attenuates endothelium‐dependent platelet inhibition in man

  2010cites this paper
• Medicinal Chemistry and Therapeutic Applications of the Gasotransmitters NO, CO, and H2S and their Prodrugs

  2010cites this paper
• S-Nitrosothiol biology and therapeutic potential in metabolic disease.

  2010cites this paper
• S‐ Nitroso Compounds, Formation, Reactions and Biological Activity

  2009cites this paper
• Nitric Oxide Donors as Platelet Inhibitors

  2009cites this paper
• Beeinflussung der zerebralen Mikrozirkulation durch Inhalation von Stickstoffmonoxid(NO)

  2009cites this paper
• Nitric oxide-releasing S-nitrosothiol-modified xerogels.

  2009cites this paper
• The effect of S-nitrosocaptopril and S-nitroso-N-acetyl-D,L-penicillamine on blood glucose concentration and haemodynamic parameters

  2009cites this paper
• Is there a rationale for the chronic use of phosphodiesterase‐5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?

  2009cites this paper
• Neuroprotective strategies in parkinson’s disease: protection against progressive nigral damage induced by free radicals

  2009cites this paper
• RESEARC HREVIEW Pharmacologica lPreconditionin gWit hHyperbari cOxygen :Ca nThis Therap yAttenuat eMyocardia lIschemi cReperfusio nInjur yan dInduce Myocardia lProtectio nvi aNitri cOxide?

  2008cites this paper
• Pharmacological preconditioning with hyperbaric oxygen: can this therapy attenuate myocardial ischemic reperfusion injury and induce myocardial protection via nitric oxide?

  2008cites this paper
• Clinical research Impaired action of nitric oxide on blood platelets in premature newborns

  2008cites this paper
• Inducible Nitric Oxide S ynthase and Atherosclerosis

  2008cites this paper
• Einfluss der Stickstoff-Monoxid-Inhalation auf den sekundären Hirnschaden nach experimentellem Schädelhirntrauma

  2008cites this paper
• Cobalt Phthalocyanine Molecular Electrode for the Electrochemical Investigation of the Release of Glutathione upon Copper‐Catalyzed Decomposition of S‐Nitrosoglutathione

  2007cites this paper
• Recent developments in nitric oxide donor drugs

  2007cites this paper
• Chapter 12 – Chronic Stable Angina

  2007cites this paper
• Nitric oxide homeostasis as a target for drug additives to cardioplegia

  2007cites this paper
• S‐nitrosoglutathione‐containing hydrogel accelerates rat cutaneous wound repair

  2007cites this paper
• Therapeutic Uses of Nitric Oxide-donating Drugs in the Treatment of Cardiovascular Diseases

  2006cites this paper
• Evaluation Of Platelet Function By Flow Cytometry

  2006cites this paper
• Einfluss von flavanolreichem Kakao auf die Endotheldysfunktion bei Rauchern

  2006cites this paper
• The many antithrombotic actions of nitric oxide.

  2006cites this paper
• Flavanols and Cardiovascular Health: Effects on the circulating NO Pool in Humans

  2006cites this paper
• Nitric oxide in cardiac transplantation.

  2006cites this paper
• Plasma nitroso compounds are decreased in patients with endothelial dysfunction.

  2006cites this paper
• Nitric oxide and its antithrombotic action in the cardiovascular system.

  2005cites this paper
• S-Nitrosoglutathione Reduces Inflammation and Protects Brain against Focal Cerebral Ischemia in a Rat Model of Experimental Stroke

  2005cites this paper
• Nitric oxide and its antithrombotic action in the cardiovascular system.

  2005cites this paper
• ESR spin trapping of a carbon-centered free radical from agonist-stimulated human platelets.

  2005cites this paper
• Original Contribution ESR spin trapping of a carbon-centered free radical from agonist-stimulated human platelets

  2005cites this paper
• Markers of Platelet Activation and Granule Secretion

  2005cites this paper
• Current status and future possibilities of nitric oxide-donor drugs: focus on S-nitrosothiols.

  2005cites this paper
• C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression.

  2005cites this paper
• THE EFFECT OF S-NITROSOGLUTATHIONE ON INSULIN RECEPTOR BEHAVIOR ON ERYTHROCYTES IN AN ANIMAL MODEL

  2004cites this paper
• Nutrachemicals in the Prevention and Treatment of Cardiovascular Disease

  2004cites this paper
• The effect of nitric oxide on glucose metabolism

  2004cites this paper
• Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects.

  2004influential citation
• The pivotal role of nitric oxide for vascular health.

  2004cites this paper
• S-nitrosothiols as nitric oxide-donors: chemistry, biology and possible future therapeutic applications.

  2004cites this paper
• The biology of hemodialysis

  2004cites this paper
• Nitric Oxide, Platelet Function, Myocardial Infarction and Reperfusion Therapies

  2004cites this paper
• Nitric oxide and S-nitrosothiols in human blood.

  2003cites this paper
• A novel S-nitrosothiol causes prolonged and selective inhibition of platelet adhesion at sites of vascular injury.

  2003cites this paper
• Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina. A preliminary study.

  2003cites this paper
• Nitric oxide, platelet function, myocardial infarction and reperfusion therapies.

  2003cites this paper
• The potential of nitric oxide therapeutics in stroke

  2003cites this paper